COAGULATION DISORDER
Clinical trials for COAGULATION DISORDER explained in plain language.
Never miss a new study
Get alerted when new COAGULATION DISORDER trials appear
Sign up with your email to follow new studies for COAGULATION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to stop deadly bleeding after birth
Disease control Recruiting nowThis study tests whether giving a clotting protein called factor XIII early can reduce blood loss in women with heavy bleeding after childbirth. About 988 women having a vaginal delivery will be randomly assigned to receive either factor XIII plus standard care or standard care a…
Matched conditions: COAGULATION DISORDER
Phase: PHASE4 • Sponsor: Christian Haslinger • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC
-
New reversal agent for blood thinners tested in urgent surgeries
Disease control Recruiting nowThis study tests a new drug called TAK-330 to reverse the effects of common blood thinners (Factor Xa inhibitors) in patients who need urgent surgery. About 328 adults will be randomly assigned to receive TAK-330 or standard care before their procedure. The main goal is to see if…
Matched conditions: COAGULATION DISORDER
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 01, 2026 17:58 UTC
-
Massive study aims to unlock safe drug dosing for kids
Knowledge-focused Recruiting nowThis study is watching how certain medicines act in the bodies of children and young adults (under 21) who are already taking them as part of their regular care. The goal is to find the safest and most effective doses for these age groups. No new drugs are being tested—just gathe…
Matched conditions: COAGULATION DISORDER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC